alprazolam has been researched along with Depression, Endogenous in 144 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pre-treatment predictors of treatment outcome were examined in a group of 144 patients with panic disorder and agoraphobia randomly allocated to alprazolam+exposure (AE), placebo+exposure (PE), alprazolam+relaxation (AR), and placebo+relaxation (PR)." | 9.07 | Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure. ( Başoğlu, M; Kuch, K; Marks, IM; Noshirvani, H; O'Sullivan, G; Swinson, RP, 1994) |
| "This study examines clinical predictors of outcome for patients with panic disorder and depression in a 16 week, placebo-controlled trial of alprazolam and imipramine (n = 126)." | 9.07 | Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. ( Deltito, JA; Keller, MB; Leon, A; Otto, MW; Pollack, MH; Rosenbaum, JF; Sachs, GS; Shear, MK, 1994) |
| "Sixteen female outpatients with borderline personality disorder and prominent behavioral dyscontrol, but without a current episode of major depression, were studied in a double-blind, crossover trial of placebo and the following four active medications: alprazolam (average dose, 4." | 9.06 | Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. ( Cowdry, RW; Gardner, DL, 1988) |
| "A case is presented in which, by a double-blind, placebo-controlled trial, alprazolam was shown to produce reversible stuttering." | 9.05 | A case report of alprazolam-induced stuttering. ( Elliott, RL; Thomas, BJ, 1985) |
| "This 8-week double-blind placebo-controlled trial investigated the relative efficacy and safety of alprazolam and buspirone in the treatment of panic disorder." | 7.68 | The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study. ( Harnett-Sheehan, K; Knapp, E; Raj, AB; Sheehan, DV; Soto, S, 1993) |
| " The charts of 78 panic disorder outpatients treated with alprazolam (mean dose 4." | 7.68 | Alprazolam in panic disorder: a retrospective analysis. ( Harvey, DS; Loosen, PT; Shelton, RC; Stewart, PM, 1993) |
| " While undergoing treatment with the minor tranquilizer alprazolam for a coincidental psychiatric disturbance, 39 patients with malignancies and an associated causalgic pain syndrome had a marked analgesic response." | 7.67 | Analgesic effect of alprazolam in patients with chronic, organic pain of malignant origin. ( Adams, F; Fernandez, F; Holmes, VF, 1987) |
| "In a 6-week double-blind trial 129 outpatients with major depressive disorder received either alprazolam, imipramine or placebo." | 7.66 | A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder. ( Chammas, S; Feighner, JP; Frost, NR; Hendrickson, G; Meredith, CH, 1983) |
| "Alprazolam appears to be an effective antidepressant in the treatment of outpatients who have a diagnosis of major depressive disorder." | 6.16 | Alprazolam as an antidepressant. ( Hollister, LE; Peabody, CA; Warner, MD; Whiteford, HA, 1988) |
| "This patient presented with symptoms of neuroleptic malignant syndrome (NMS), thus demonstrating that NMS-like symptoms can occur after combined paroxetine and alprazolam treatment." | 5.33 | Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam. ( Fujita, K; Ichihashi, K; Inoue, K; Okazaki, Y; Tanii, H, 2006) |
| "Pre-treatment predictors of treatment outcome were examined in a group of 144 patients with panic disorder and agoraphobia randomly allocated to alprazolam+exposure (AE), placebo+exposure (PE), alprazolam+relaxation (AR), and placebo+relaxation (PR)." | 5.07 | Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure. ( Başoğlu, M; Kuch, K; Marks, IM; Noshirvani, H; O'Sullivan, G; Swinson, RP, 1994) |
| "This study examines clinical predictors of outcome for patients with panic disorder and depression in a 16 week, placebo-controlled trial of alprazolam and imipramine (n = 126)." | 5.07 | Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. ( Deltito, JA; Keller, MB; Leon, A; Otto, MW; Pollack, MH; Rosenbaum, JF; Sachs, GS; Shear, MK, 1994) |
| "Clinical outcome and adverse effects associated with concurrent alprazolam and imipramine administration were studied in 29 patients with major depressive disorder who completed a 6-week trial in which they served as their own controls." | 5.06 | Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramine. ( Antal, EJ; Ereshefsky, L; Evans, RL; Grimmig, J; Hamann, G; Lobeck, F; Rawls, WN; Smith, RB; Wells, BG, 1988) |
| "Ninety-eight outpatients with major depressive disorder were treated with alprazolam, imipramine, or placebo in a 6-week, double-blind study." | 5.06 | Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients. ( Mendels, J; Schless, AP, 1986) |
| "The antidepressant efficacy of alprazolam (ALP) was tested in a double-blind controlled comparison with desipramine (DMI) and an ALP-DMI combination in outpatients diagnosed with major depressive disorder by Research Diagnostic Criteria (90% met criteria for endogenous subtype)." | 5.06 | Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients. ( Edwards, JH; Fawcett, J; Jeffriess, H; Kravitz, HM, 1987) |
| "Sixteen female outpatients with borderline personality disorder and prominent behavioral dyscontrol, but without a current episode of major depression, were studied in a double-blind, crossover trial of placebo and the following four active medications: alprazolam (average dose, 4." | 5.06 | Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. ( Cowdry, RW; Gardner, DL, 1988) |
| "Two hundred forty-one outpatients with a DSM-III diagnosis of major depressive disorder participated in a six-week double-blind therapeutic trial of alprazolam, diazepam, imipramine hydrochloride, and placebo." | 5.06 | Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression. ( Amsterdam, JD; Chung, HR; Csanalosi, IB; Hurowitz, AM; Kaplan, M; London, J; Rickels, K; Wiseman, K, 1987) |
| "Fifty-two adult depressed outpatients fulfilling Research Diagnostic Criteria for Definite Major Depressive Disorder were enrolled in a double-blind study comparing the antidepressant effects of alprazolam versus desipramine." | 5.06 | A comparison of the efficacy and safety of alprazolam and desipramine in depressed outpatients. ( Buchanan, RA; Fleming, JA; Gibson, RE; Keller, FD; Remick, RA, 1988) |
| "A woman with major depressive disorder and refractory, incapacitating migraine headaches responded to alprazolam in a double-blind, placebo-controlled study." | 5.05 | Refractory migraine headache controlled with alprazolam: case report. ( Othmer, E; Othmer, SC; Strong, DM; Varanka, TM, 1985) |
| "Fifty-four patients (34 outpatients, 20 inpatients) fulfilling Research Diagnostic Criteria for Definite Major Depressive Disorder were enrolled in a double-blind study comparing the antidepressant effects of alprazolam versus desipramine." | 5.05 | A comparison of the safety and efficacy of alprazolam and desipramine in moderately severe depression. ( Buchanan, RA; Fleming, JA; Hamilton, P; Keller, FD; Loomer, F; Miles, JE; Remick, RA, 1985) |
| "Patients who met DSM-III criteria for agoraphobia with panic attacks underwent dexamethasone suppression tests (DSTs) before, during, and after treatment with alprazolam or placebo." | 5.05 | Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks. ( Chaudhry, D; Clancy, J; Coryell, W; Crowe, R; Noyes, R, 1985) |
| "A case is presented in which, by a double-blind, placebo-controlled trial, alprazolam was shown to produce reversible stuttering." | 5.05 | A case report of alprazolam-induced stuttering. ( Elliott, RL; Thomas, BJ, 1985) |
| "Therapeutic efficacy for depression and panic disorder has been demonstrated with the triazolobenzodiazepine alprazolam." | 4.78 | Alprazolam and depression: a review of risks and benefits. ( Fawcett, J; Kravitz, HM; Newman, AJ, 1993) |
| "A review of the worldwide published literature was conducted to assess the efficacy and safety of alprazolam for the treatment of anxiety disorders, panic disorder, and depression in comparison with those of other active drugs (including other benzodiazepines and antidepressant medications)." | 4.78 | A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature. ( Cohon, MS; Jonas, JM, 1993) |
| "Alprazolam has antidepressant activity and has been shown to be similar in efficacy to imipramine in the treatment of unipolar depression." | 3.75 | Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression. ( Brogden, RN; Dawson, GW; Jue, SG, 1984) |
| " The charts of 78 panic disorder outpatients treated with alprazolam (mean dose 4." | 3.68 | Alprazolam in panic disorder: a retrospective analysis. ( Harvey, DS; Loosen, PT; Shelton, RC; Stewart, PM, 1993) |
| "This 8-week double-blind placebo-controlled trial investigated the relative efficacy and safety of alprazolam and buspirone in the treatment of panic disorder." | 3.68 | The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study. ( Harnett-Sheehan, K; Knapp, E; Raj, AB; Sheehan, DV; Soto, S, 1993) |
| "Sixty patients with agoraphobia with panic attacks or panic disorder who completed a 4-month combined drug and behavioral group treatment program and were discharged on a regimen of alprazolam were interviewed 1." | 3.67 | Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study. ( Charney, DS; Krystal, JH; Nagy, LM; Woods, SW, 1989) |
| "Two patients treated with alprazolam for panic disorder and agoraphobia developed a manic episode." | 3.67 | Alprazolam-induced manic episode in two patients with panic disorder. ( Fleury, D; Pecknold, JC, 1986) |
| " While undergoing treatment with the minor tranquilizer alprazolam for a coincidental psychiatric disturbance, 39 patients with malignancies and an associated causalgic pain syndrome had a marked analgesic response." | 3.67 | Analgesic effect of alprazolam in patients with chronic, organic pain of malignant origin. ( Adams, F; Fernandez, F; Holmes, VF, 1987) |
| "In a 6-week double-blind trial 129 outpatients with major depressive disorder received either alprazolam, imipramine or placebo." | 3.66 | A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder. ( Chammas, S; Feighner, JP; Frost, NR; Hendrickson, G; Meredith, CH, 1983) |
| "Desipramine-treated subjects showed gradual improvement over the course of the study, and the improvement in week 1 was not so strongly predictive of overall improvement." | 2.67 | Antidepressant or antianxiety? A study of the efficacy of antidepressant medication. ( Edwards, J; Fawcett, J; Fogg, L; Kravitz, HM, 1990) |
| " The average maximum dosage of alprazolam was 2." | 2.67 | A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly. ( Greenwald, S; Prusoff, B; Sholomskas, AJ; Weissman, MM, 1992) |
| " Drug dosage was determined in a fixed-flexible design resulting in mean final doses of alprazolam 3." | 2.67 | Alprazolam and amitriptyline in the treatment of moderate depression. ( Browne, M; Lapierre, YD; Oyewumi, K; Sarantidis, D, 1994) |
| "Alprazolam was effective in reducing panic and depressive symptomatology in both depressed and nondepressed subjects with panic disorder." | 2.66 | Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment. ( Burrows, GD; DuPont, RL; Lesser, IM; Lydiard, RB; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1988) |
| "Alprazolam was more effective than placebo as measured by the Hamilton Anxiety Rating Scale, the Self-Rating Symptom Scale, Target Symptoms, Physician's Global Impressions, and Patient's Global Impressions." | 2.65 | Alprazolam in clinically anxious patients with depressed mood. ( Aden, GC, 1983) |
| "Alprazolam was at least as effective as imipramine in relieving depressive symptoms, significantly more effective in relieving somatic symptoms, and showed an earlier onset of activity in some measurements." | 2.65 | Comparison of alprazolam, imipramine, and placebo in the treatment of depression. ( Aden, GC; Fabre, LF; Feighner, JP; Rickels, K; Smith, WT, 1983) |
| "Panic disorder is a serious, often chronic condition that warrants vigorous treatment." | 2.38 | Psychopharmacological treatment of panic disorder. ( Bowden, CL, 1992) |
| "One patient died of pulmonary edema and subsequent heart failure, but the rest of the patients recovered without any sequelae." | 1.34 | Hemoperfusion in the treatment of acute clozapine intoxication in China. ( Cai, ZJ; He, JL; Li, WB; Ungvari, GS; Xiang, YT, 2007) |
| "This patient presented with symptoms of neuroleptic malignant syndrome (NMS), thus demonstrating that NMS-like symptoms can occur after combined paroxetine and alprazolam treatment." | 1.33 | Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam. ( Fujita, K; Ichihashi, K; Inoue, K; Okazaki, Y; Tanii, H, 2006) |
| "5 mg of alprazolam on Day 1 the mean elimination half-life was 11." | 1.28 | Pharmacokinetics of alprazolam in geriatric patients with neurotic depression. ( Agrell, B; Dehlin, O; Kullingsjö, H; Lidén, A; Moser, G; Olsen, I, 1991) |
| "All had withdrawal symptoms, six demonstrated tolerance, and at least four had substantial social or occupational impairment secondary to drug use." | 1.27 | Alprazolam dependence in seven patients. ( Juergens, SM; Morse, RM, 1988) |
| "Alprazolam is a triazolobenzodiazepine, a derivative of the benzodiazepines." | 1.26 | Alprazolam (Xanax, the Upjohn Company). ( Evans, RL, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 86 (59.72) | 18.7374 |
| 1990's | 50 (34.72) | 18.2507 |
| 2000's | 7 (4.86) | 29.6817 |
| 2010's | 1 (0.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mermi, O | 1 |
| Atmaca, M | 1 |
| Möller, HJ | 1 |
| Ibadullaev, ZP | 1 |
| Tanii, H | 1 |
| Ichihashi, K | 1 |
| Inoue, K | 1 |
| Fujita, K | 1 |
| Okazaki, Y | 1 |
| He, JL | 1 |
| Xiang, YT | 1 |
| Li, WB | 1 |
| Cai, ZJ | 1 |
| Ungvari, GS | 1 |
| Evans, RL | 2 |
| Feighner, JP | 6 |
| Crook, T | 1 |
| Aden, GC | 2 |
| Pies, R | 1 |
| France, RD | 1 |
| Krishnan, KR | 1 |
| Pitts, WM | 1 |
| Fann, WE | 1 |
| Sajadi, C | 1 |
| Snyder, S | 1 |
| Fabre, LF | 1 |
| Rickels, K | 3 |
| Smith, WT | 2 |
| Meredith, CH | 1 |
| Frost, NR | 1 |
| Chammas, S | 1 |
| Hendrickson, G | 1 |
| Rush, AJ | 2 |
| Roffwarg, HP | 1 |
| Giles, DE | 1 |
| Schlesser, MA | 1 |
| Fairchild, C | 1 |
| Tarell, J | 1 |
| Dawson, GW | 1 |
| Jue, SG | 1 |
| Brogden, RN | 1 |
| Lenox, RH | 1 |
| Shipley, JE | 1 |
| Peyser, JM | 1 |
| Williams, JM | 1 |
| Weaver, LA | 1 |
| Rosenbaum, JF | 6 |
| Woods, SW | 2 |
| Groves, JE | 1 |
| Klerman, GL | 5 |
| Tollefson, G | 1 |
| Tuason, VB | 1 |
| Talmud, J | 1 |
| Straughan, JL | 1 |
| Robins, AH | 1 |
| Levy, AB | 1 |
| Davis, J | 1 |
| Bidder, TG | 1 |
| Ansseau, M | 1 |
| Ansoms, C | 1 |
| Beckers, G | 1 |
| Bogaerts, M | 1 |
| Botte, L | 1 |
| De Buck, R | 1 |
| Diricq, S | 1 |
| Dumortier, A | 1 |
| Jansegers, E | 1 |
| Owieczka, J | 1 |
| Silberman, EK | 1 |
| Sullivan, JL | 1 |
| Sheehan, DV | 2 |
| Klein, DF | 2 |
| Zung, WW | 1 |
| King, RE | 1 |
| Friedman, MJ | 1 |
| Stolk, JM | 1 |
| Harris, PQ | 1 |
| Cooper, TB | 1 |
| Zarcone, VP | 1 |
| Benson, KL | 1 |
| Greene, KA | 1 |
| Csernansky, JG | 1 |
| Faull, KF | 1 |
| Leon, AC | 3 |
| Marzuk, PM | 1 |
| Portera, L | 3 |
| Campbell, M | 1 |
| Cueva, JE | 1 |
| Romach, M | 1 |
| Busto, U | 1 |
| Somer, G | 1 |
| Kaplan, HL | 2 |
| Sellers, E | 1 |
| Cano-Muñoz, JL | 1 |
| Montejo-Iglesias, ML | 1 |
| Yañez-Saez, RM | 1 |
| Gálvez-Borrero, IM | 1 |
| Başoğlu, M | 1 |
| Marks, IM | 1 |
| Swinson, RP | 2 |
| Noshirvani, H | 1 |
| O'Sullivan, G | 1 |
| Kuch, K | 1 |
| Amsterdam, JD | 2 |
| Hornig-Rohan, M | 1 |
| Maislin, G | 1 |
| Rosenfeld, DS | 1 |
| Furman, Y | 1 |
| Pollack, MH | 5 |
| Otto, MW | 2 |
| Sachs, GS | 3 |
| Leon, A | 2 |
| Shear, MK | 3 |
| Deltito, JA | 3 |
| Keller, MB | 2 |
| Patten, SB | 1 |
| Fick, GH | 1 |
| Williams, JV | 1 |
| Lapierre, YD | 1 |
| Browne, M | 1 |
| Oyewumi, K | 1 |
| Sarantidis, D | 1 |
| Goldenberg, I | 1 |
| Jonas, JM | 1 |
| Cohon, MS | 1 |
| Kravitz, HM | 4 |
| Fawcett, J | 4 |
| Newman, AJ | 1 |
| Lavori, PW | 1 |
| Goldenberg, IM | 1 |
| Baker, LA | 1 |
| Shear, K | 1 |
| Raj, AB | 1 |
| Harnett-Sheehan, K | 1 |
| Soto, S | 1 |
| Knapp, E | 1 |
| Shelton, RC | 1 |
| Harvey, DS | 1 |
| Stewart, PM | 1 |
| Loosen, PT | 1 |
| Petty, F | 1 |
| Trivedi, MH | 1 |
| Fulton, M | 1 |
| Ketter, TA | 1 |
| Callahan, AM | 1 |
| Post, R | 1 |
| Lepola, U | 1 |
| Koponen, H | 1 |
| Leinonen, E | 1 |
| Reddy, J | 1 |
| Khanna, S | 1 |
| Anand, U | 1 |
| Banerjee, A | 1 |
| Pollock, RA | 1 |
| Srisurapanont, M | 1 |
| Boonyanaruthee, V | 1 |
| Yoo, K | 1 |
| Nazario, L | 1 |
| Hanau, M | 1 |
| Sampson, S | 1 |
| Goldbaum, R | 1 |
| Millman, D | 1 |
| Cannizzaro, C | 1 |
| Cannizzaro, E | 1 |
| Gagliano, M | 1 |
| Mineo, A | 1 |
| Feiner, NF | 1 |
| Solov'eva, AD | 1 |
| Filatova, EG | 1 |
| Averkina, NA | 1 |
| Frémont, P | 1 |
| Sandyk, R | 1 |
| Dann, LC | 1 |
| Tiller, JW | 1 |
| Schweitzer, I | 1 |
| Romach, MK | 1 |
| Somer, GR | 1 |
| Sobell, LC | 1 |
| Sobell, MB | 1 |
| Sellers, EM | 1 |
| Korn, ML | 1 |
| Kotler, M | 1 |
| Molcho, A | 1 |
| Botsis, AJ | 1 |
| Grosz, D | 1 |
| Chen, C | 1 |
| Plutchik, R | 1 |
| Brown, SL | 1 |
| van Praag, HM | 1 |
| Glod, CA | 1 |
| Bowden, CL | 1 |
| Weissman, MM | 1 |
| Prusoff, B | 1 |
| Sholomskas, AJ | 1 |
| Greenwald, S | 1 |
| Mooney, JJ | 4 |
| Schatzberg, AF | 4 |
| Cole, JO | 4 |
| Samson, JA | 1 |
| Waternaux, C | 1 |
| Gerson, B | 3 |
| Pappalardo, KM | 2 |
| Schildkraut, JJ | 4 |
| Maier, W | 1 |
| Rosenberg, R | 3 |
| Argyle, N | 2 |
| Buller, R | 1 |
| Roth, M | 1 |
| Brandon, S | 1 |
| Benkert, O | 1 |
| Dehlin, O | 1 |
| Kullingsjö, H | 1 |
| Lidén, A | 2 |
| Agrell, B | 1 |
| Moser, G | 1 |
| Olsen, I | 1 |
| Bech, P | 2 |
| Mellergård, M | 2 |
| Ottosson, JO | 2 |
| Rosenberg, NK | 1 |
| Cowley, DS | 1 |
| Dager, SR | 1 |
| Roy-Byrne, PP | 1 |
| Avery, DH | 1 |
| Dunner, DL | 1 |
| Edwards, JG | 1 |
| Inman, WH | 1 |
| Pearce, GL | 1 |
| Rawson, NS | 1 |
| Melvin, JA | 1 |
| Lydiard, RB | 3 |
| Crowe, CM | 1 |
| Laraia, MT | 2 |
| Fossey, MD | 1 |
| Ballenger, JC | 2 |
| Edwards, JH | 2 |
| Fogg, L | 2 |
| Edwards, J | 1 |
| Bernstein, GA | 1 |
| Garfinkel, BD | 1 |
| Borchardt, CM | 1 |
| O'Neil, C | 1 |
| Asher, R | 1 |
| Meltzer-Brody, S | 1 |
| Risse, SC | 1 |
| Whitters, A | 1 |
| Burke, J | 1 |
| Chen, S | 1 |
| Scurfield, RM | 1 |
| Raskind, MA | 1 |
| Sasa, H | 1 |
| Otani, K | 2 |
| Kondo, T | 1 |
| Kaneko, S | 1 |
| Fukushima, Y | 1 |
| Cesková, E | 2 |
| Svestka, J | 2 |
| Náhunek, K | 2 |
| Obrovská, V | 2 |
| Borison, RL | 1 |
| Sinha, D | 1 |
| Albrecht, JW | 1 |
| Geber, S | 1 |
| Diamond, BI | 1 |
| Hocking, K | 1 |
| Adan, F | 1 |
| Siris, SG | 1 |
| Banerji, JR | 1 |
| Brantingham, P | 1 |
| McEwan, GD | 1 |
| Mason, J | 1 |
| Munt, DF | 1 |
| Renton, RL | 1 |
| Scott, AP | 1 |
| Strakova, JM | 1 |
| Stevens, V | 1 |
| Rysánek, R | 1 |
| Pyke, RE | 2 |
| Nagy, LM | 1 |
| Krystal, JH | 1 |
| Charney, DS | 1 |
| Kizuka, PP | 2 |
| Salomon, M | 1 |
| Lerbinger, J | 1 |
| Elliott, RL | 2 |
| Rapaport, M | 1 |
| Braff, DL | 1 |
| O'Connor, WT | 1 |
| Earley, B | 1 |
| Leonard, BE | 1 |
| Thomas, BJ | 1 |
| Rasmussen, SB | 1 |
| Mørck, H | 1 |
| Imlah, NW | 1 |
| Coryell, W | 2 |
| Noyes, R | 2 |
| Clancy, J | 1 |
| Crowe, R | 1 |
| Chaudhry, D | 1 |
| Pecknold, JC | 2 |
| Fleury, D | 1 |
| Mendels, J | 1 |
| Schless, AP | 1 |
| Mayerhoff, D | 1 |
| Vital-Herne, J | 1 |
| Lesser, M | 1 |
| Brenner, R | 1 |
| French, AP | 1 |
| Moranville, JT | 1 |
| Ostrow, D | 1 |
| Wells, BG | 1 |
| Ereshefsky, L | 1 |
| Antal, EJ | 1 |
| Lobeck, F | 1 |
| Rawls, WN | 1 |
| Hamann, G | 1 |
| Grimmig, J | 1 |
| Smith, RB | 1 |
| Remick, RA | 2 |
| Keller, FD | 2 |
| Buchanan, RA | 2 |
| Gibson, RE | 1 |
| Fleming, JA | 2 |
| Müller, WE | 2 |
| Bauer, K | 2 |
| Rost, W | 2 |
| Filser, JG | 1 |
| Fischer, M | 1 |
| Gattaz, WF | 2 |
| Hübner, CK | 1 |
| Juergens, SM | 1 |
| Morse, RM | 1 |
| Cowdry, RW | 1 |
| Gardner, DL | 1 |
| Warner, MD | 1 |
| Peabody, CA | 1 |
| Whiteford, HA | 1 |
| Hollister, LE | 1 |
| Lesser, IM | 1 |
| Rubin, RT | 1 |
| Rifkin, A | 1 |
| Burrows, GD | 1 |
| DuPont, RL | 1 |
| Singh, AN | 1 |
| Nair, NP | 1 |
| Suranyi-Cadotte, B | 1 |
| Schwartz, G | 1 |
| Lizondo, E | 1 |
| Ettigi, PE | 1 |
| Goldberg, SC | 1 |
| Schulz, PM | 1 |
| Hamer, RM | 1 |
| Blackard, WG | 1 |
| Chung, HR | 1 |
| Csanalosi, IB | 1 |
| Hurowitz, AM | 1 |
| London, J | 1 |
| Wiseman, K | 1 |
| Kaplan, M | 1 |
| Jeffriess, H | 1 |
| Kraus, M | 1 |
| Bertilsson, L | 1 |
| Aberg-Wistedt, A | 1 |
| Spina, E | 1 |
| Terrell, HB | 1 |
| Bleich, A | 1 |
| Grinspoon, A | 1 |
| Garb, R | 1 |
| Overall, JE | 2 |
| Biggs, J | 1 |
| Jacobs, M | 1 |
| Holden, K | 1 |
| Donachie, ND | 1 |
| Faillace, LA | 1 |
| Frye, CR | 1 |
| Schmauss, M | 1 |
| Laakmann, G | 1 |
| Blaschke, D | 1 |
| Howell, EF | 1 |
| Gilbert, A | 1 |
| Hendrie, HC | 1 |
| Deicken, RF | 1 |
| Fernandez, F | 1 |
| Adams, F | 1 |
| Holmes, VF | 1 |
| Eriksson, B | 1 |
| Nagy, A | 1 |
| Starmark, JE | 1 |
| Thelander, U | 1 |
| Beutler, LE | 1 |
| Scogin, F | 1 |
| Kirkish, P | 1 |
| Schretlen, D | 1 |
| Corbishley, A | 1 |
| Hamblin, D | 1 |
| Meredith, K | 1 |
| Potter, R | 1 |
| Bamford, CR | 1 |
| Levenson, AI | 1 |
| Thweatt, RW | 1 |
| Ries, RK | 1 |
| Wittkowsky, AK | 1 |
| Kantor, SJ | 1 |
| McCormick, WO | 1 |
| Kahn, JP | 1 |
| Stevenson, E | 1 |
| Topol, P | 1 |
| Carr, AC | 1 |
| Ancill, RJ | 1 |
| Empson, P | 1 |
| Othmer, SC | 1 |
| Othmer, E | 1 |
| Varanka, TM | 1 |
| Strong, DM | 1 |
| Akiskal, HS | 1 |
| Hamilton, P | 1 |
| Loomer, F | 1 |
| Miles, JE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Role of Orexin in Human Panic Disorder[NCT02593682] | Phase 4 | 3 participants (Actual) | Interventional | 2016-05-31 | Completed | ||
| Psychopharmacology of Biogenic Amines in Depression[NCT00320632] | Phase 4 | 43 participants | Interventional | 1990-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
19 reviews available for alprazolam and Depression, Endogenous
| Article | Year |
|---|---|
Anxiety associated with comorbid depression.
Topics: Adult; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzodiazepi | 2002 |
Diagnosis and treatment of mixed anxiety-depression in the elderly.
Topics: Adult; Age Factors; Aged; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Age | 1982 |
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; | 1984 |
The new generation of antidepressants.
Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Brompheniramin | 1983 |
Atypical depression.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Character; Chronic Disease; Clinic | 1984 |
Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II.
Topics: Adolescent; Alprazolam; Anticonvulsants; Antipsychotic Agents; Anxiety, Separation; Bipolar Disorder | 1995 |
Pure sleep panic: two case reports and a review of the literature.
Topics: Adult; Alcoholism; Alprazolam; Arousal; Combined Modality Therapy; Depressive Disorder; Female; Huma | 1994 |
A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as | 1993 |
Alprazolam and depression: a review of risks and benefits.
Topics: Adolescent; Adult; Aged; Alprazolam; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; | 1993 |
Benzodiazepines as antidepressants: does GABA play a role in depression?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Chlordiazepoxide; Depressive Disorder; Diazepam; | 1995 |
Clinical issues in the long-term treatment of panic disorder.
Topics: Age Factors; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Child; Cognitive B | 1996 |
Alprazolam and standard antidepressants in the treatment of depression: a meta-analysis of the antidepressant effect.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Depressive Disorder; Humans; Randomized Cont | 1997 |
Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder.
Topics: Adolescent; Age of Onset; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Cognitive Behavior | 2001 |
Benzodiazepines. Depressants or antidepressants?
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Depressive Disorder; Humans; Substa | 1992 |
Xanax: pros and cons.
Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Female; Humans; Panic Disorder; Stress Di | 1992 |
Psychopharmacological treatment of panic disorder.
Topics: Adult; Alprazolam; Antidepressive Agents, Tricyclic; Benzodiazepines; Depressive Disorder; Female; H | 1992 |
Validation criteria for panic disorder as a nosological entity.
Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Humans; Imipramine; Panic; Psychiatric Status Ra | 1991 |
Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Depressive Disorder; Humans; Panic | 1990 |
Alprazolam as an antidepressant.
Topics: Alprazolam; Ambulatory Care; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive | 1988 |
54 trials available for alprazolam and Depression, Endogenous
| Article | Year |
|---|---|
[Efficacy of alprazolam (xanax) in mental disorders in patients with left- and right hemispheric ischemic stroke].
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Brain Ischemia; Depressive Disorder; Female; Fun | 2004 |
Benzodiazepines as antidepressants. A triazolobenzodiazepine used to treat depression.
Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressiv | 1982 |
Alprazolam in clinically anxious patients with depressed mood.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depres | 1983 |
Comparison of alprazolam, imipramine, and placebo in the treatment of depression.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; | 1983 |
Open label study of alprazolam in severely depressed inpatients.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depre | 1983 |
Psychobiological predictors of antidepressant drug response.
Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressiv | 1983 |
Alprazolam: a review of its pharmacodynamic properties and efficacy in the treatment of anxiety and depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; | 1984 |
Double-blind comparison of alprazolam versus imipramine in the inpatient treatment of major depressive illness.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disord | 1984 |
Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; | 1984 |
The new generation of antidepressants.
Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Brompheniramin | 1983 |
Atypical depression.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bipolar Disorder; Character; Chronic Disease; Clinic | 1984 |
Identification and treatment of masked depression in a general medical practice.
Topics: Aged; Alprazolam; Attitude to Health; Benzodiazepines; Depressive Disorder; Family Practice; Humans; | 1983 |
The effect of chronic alprazolam on sleep and bioamine metabolites in depression.
Topics: Adult; Alprazolam; Depressive Disorder; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindol | 1994 |
Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure.
Topics: Adult; Agoraphobia; Alprazolam; Combined Modality Therapy; Depressive Disorder; Desensitization, Psy | 1994 |
Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
Topics: Adult; Aged; Alprazolam; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Imip | 1994 |
Alprazolam and amitriptyline in the treatment of moderate depression.
Topics: Adolescent; Adult; Aged; Alprazolam; Amitriptyline; Depressive Disorder; Dose-Response Relationship, | 1994 |
A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression.
Topics: Adult; Aged; Alprazolam; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; | 1993 |
Effect size as a measure of symptom-specific drug change in clinical trials.
Topics: Adult; Alprazolam; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Imipramine; Male; | 1993 |
Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
Topics: Adult; Aged; Alprazolam; Arousal; Depressive Disorder; Double-Blind Method; Female; Humans; Imiprami | 1993 |
[Therapy of autonomic disorders by xanax (alprazolam)].
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Autonomic Nervous System Diseases; Depressive Disorder; Dose | 2000 |
A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
Topics: Aged; Aged, 80 and over; Alprazolam; Depressive Disorder; Double-Blind Method; Female; Humans; Imipr | 1992 |
Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Female; | 1991 |
Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
Topics: Alprazolam; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; | 1991 |
Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Arousal; Depressive Disorder; Dose-Response Relationship, Drug | 1991 |
Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Depressive Disorder; Humans; Panic | 1990 |
Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
Topics: Adult; Alprazolam; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; | 1991 |
Effect of alprazolam on depression in panic disorder.
Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Dose-Response Relations | 1991 |
Challenging the amphetamine challenge test: report of an antidepressant treatment study.
Topics: Adult; Alprazolam; Depressive Disorder; Desipramine; Dextroamphetamine; Double-Blind Method; Female; | 1990 |
Antidepressant or antianxiety? A study of the efficacy of antidepressant medication.
Topics: Adult; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Desipramine; Dr | 1990 |
Comparative studies of pharmacotherapy for school refusal.
Topics: Adjustment Disorders; Adolescent; Alprazolam; Anxiety Disorders; Child; Depressive Disorder; Double- | 1990 |
Double blind comparison of alprazolam with dosulepine in endogenous depression.
Topics: Adult; Aged; Alprazolam; Depressive Disorder; Dibenzothiepins; Dothiepin; Double-Blind Method; Femal | 1989 |
Double-blind comparison of 3- and 6-mg fixed doses of alprazolam vs. placebo in outpatients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Alprazolam; Depressive Disorder; Double-Blind Method; Female; Humans; Male; | 1989 |
A comparison of alprazolam with amitriptyline in the treatment of patients with neurotic or reactive depression. A report of a randomised, double blind study by a General Practitioner Working Party.
Topics: Adult; Aged; Alprazolam; Amitriptyline; Depressive Disorder; Double-Blind Method; Female; Humans; Ma | 1989 |
Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.
Topics: Adult; Alcoholism; Alprazolam; Ambulatory Care; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines; | 1985 |
A case report of alprazolam-induced stuttering.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Dos | 1985 |
An evaluation of alprazolam in the treatment of reactive or neurotic (secondary) depression.
Topics: Adjustment Disorders; Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clinical | 1985 |
Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depressive Disorder; Dexametha | 1985 |
Comparative efficacy of alprazolam, imipramine, and placebo administered once a day in treating depressed patients.
Topics: Adolescent; Adult; Alprazolam; Ambulatory Care; Anti-Anxiety Agents; Benzodiazepines; Clinical Trial | 1986 |
The new generation antidepressants: promising innovations or disappointments?
Topics: Alprazolam; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trials as Topic; | 1985 |
Clinical outcome and adverse effect profile associated with concurrent administration of alprazolam and imipramine.
Topics: Adult; Alprazolam; Blood Pressure; Clinical Trials as Topic; Depressive Disorder; Dose-Response Rela | 1988 |
A comparison of the efficacy and safety of alprazolam and desipramine in depressed outpatients.
Topics: Adult; Alprazolam; Clinical Trials as Topic; Depressive Disorder; Desipramine; Double-Blind Method; | 1988 |
Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.
Topics: Adult; Alprazolam; Ambulatory Care; Borderline Personality Disorder; Carbamazepine; Clinical Trials | 1988 |
Alprazolam as an antidepressant.
Topics: Alprazolam; Ambulatory Care; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive | 1988 |
Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Do | 1988 |
A double blind comparison of alprazolam and amitriptyline hydrochloride in the treatment of nonpsychotic depression.
Topics: Adult; Alprazolam; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method | 1988 |
Cortisol differentially predicts response to imipramine and alprazolam.
Topics: Adult; Alprazolam; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Human | 1988 |
Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
Topics: Adult; Alprazolam; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Diazepam; Double- | 1987 |
Alprazolam: an antidepressant? Alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients.
Topics: Adolescent; Adult; Alprazolam; Clinical Trials as Topic; Depressive Disorder; Desipramine; Double-Bl | 1987 |
Comparison of alprazolam and imipramine for treatment of outpatient depression.
Topics: Adolescent; Adult; Alprazolam; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Doubl | 1987 |
Implications of restrictive diagnosis for compliance to antidepressant drug therapy: alprazolam versus imipramine.
Topics: Alprazolam; Ambulatory Care; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Hum | 1987 |
Alprazolam compared to amitriptyline in the treatment of major depression.
Topics: Adolescent; Adult; Aged; Alprazolam; Amitriptyline; Depressive Disorder; Double-Blind Method; Female | 1987 |
Group cognitive therapy and alprazolam in the treatment of depression in older adults.
Topics: Aged; Alprazolam; Behavior Therapy; Cognition; Combined Modality Therapy; Depressive Disorder; Femal | 1987 |
Refractory migraine headache controlled with alprazolam: case report.
Topics: Alprazolam; Animals; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1985 |
A comparison of the safety and efficacy of alprazolam and desipramine in moderately severe depression.
Topics: Adult; Alprazolam; Antidepressive Agents; Benzodiazepines; Depressive Disorder; Desipramine; Humans | 1985 |
76 other studies available for alprazolam and Depression, Endogenous
| Article | Year |
|---|---|
[Duloxetine-Induced Hypertension: A Case Report].
Topics: Alprazolam; Anti-Anxiety Agents; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combina | 2016 |
Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam.
Topics: Aged; Alprazolam; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Therapy, Combi | 2006 |
Hemoperfusion in the treatment of acute clozapine intoxication in China.
Topics: Acute Disease; Adult; Alprazolam; Antipsychotic Agents; China; Clonazepam; Clozapine; Depressive Dis | 2007 |
Alprazolam (Xanax, the Upjohn Company).
Topics: Adjustment Disorders; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressiv | 1981 |
Alprazolam (Xanax).
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Humans | 1982 |
Alprazolam for panic disorder and depression.
Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive D | 1983 |
Alprazolam for endogenous depression.
Topics: Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depressive Disorder; Female; Humans; Middle Aged | 1983 |
Alprazolam in older depressed inpatients.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depressive Disorder; Drug Evaluation; Hospit | 1983 |
A double-blind comparison of alprazolam vs. imipramine and placebo in the treatment of major depressive disorder.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depressive Disorder; Double-Blind Method; F | 1983 |
Emergence of hostility during alprazolam treatment.
Topics: Adult; Alprazolam; Anger; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disord | 1984 |
Recognition of depressive syndromes, tricyclics, and the second generation antidepressants.
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Depressive Disor | 1984 |
Alprazolam--a new triazolobenzodiazepine.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Drug Inter | 1984 |
Successful treatment of endogenous depression with alprazolam in a patient with recent cardiac disease: case report.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Coronary Disease; Depressive Di | 1984 |
Delineation of anxiety and phobic disorders responsive to monoamine oxidase inhibitors: implications for classification.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Bupropion; Depressive Disorder; Dexamethasone; Fear; | 1984 |
Psychopharmacologic treatment of panic disorder.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Depressive Disorde | 1984 |
Serum dopamine-beta-hydroxylase activity in depression and anxiety.
Topics: Adult; Aged; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Depression; Depressive Disorde | 1984 |
More reliable outcome measures can reduce sample size requirements.
Topics: Alprazolam; Depressive Disorder; Humans; Imipramine; Panic Disorder; Placebos; Psychiatric Status Ra | 1995 |
Clinical aspects of chronic use of alprazolam and lorazepam.
Topics: Alprazolam; Ambulatory Care; Anxiety Disorders; Depressive Disorder; Drug Administration Schedule; F | 1995 |
Possible serotonin syndrome following the combined administration of clomipramine and alprazolam.
Topics: Aged; Alprazolam; Clomipramine; Depressive Disorder; Female; Humans; Serotonin; Syndrome | 1995 |
Efficacy of alprazolam in reducing fluoxetine-induced jitteriness in patients with major depression.
Topics: Adult; Akathisia, Drug-Induced; Alprazolam; Ambulatory Care; Depressive Disorder; Drug Therapy, Comb | 1994 |
Statistical heterogeneity and centre effects in clinical trials of alprazolam.
Topics: Alprazolam; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Dose-Re | 1994 |
The relative efficacy of high-dose buspirone and alprazolam in the treatment of panic disorder: a double-blind placebo-controlled study.
Topics: Adolescent; Adult; Alprazolam; Benzodiazepines; Buspirone; Comorbidity; Depressive Disorder; Double- | 1993 |
Alprazolam in panic disorder: a retrospective analysis.
Topics: Adult; Agoraphobia; Alprazolam; Depressive Disorder; Female; Humans; Male; Panic Disorder; Psychiatr | 1993 |
Nefazodone relief of alprazolam interdose dysphoria: a potential therapeutic benefit of 3A3/4 inhibition.
Topics: Alprazolam; Antidepressive Agents, Second-Generation; Anxiety; Cytochrome P-450 Enzyme Inhibitors; D | 1996 |
A naturalistic 6-year follow-up study of patients with panic disorder.
Topics: Adult; Alcoholism; Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Comorbidity; D | 1996 |
Alprazolam-induced hypomania.
Topics: Adult; Alprazolam; Anxiety Disorders; Bipolar Disorder; Depressive Disorder; Female; Humans; Psychia | 1996 |
Reevaluation of "Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depression".
Topics: Alprazolam; Anti-Anxiety Agents; Depressive Disorder; Humans; Meta-Analysis as Topic; Suicide | 1997 |
Locomotor and antidepressant-like effects of 5-HT(1A) agonist LY 228729 in prenatally benzodiazepine-exposed rats.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Depressive Disorder; Diazepam; Ergo | 1998 |
Antiepileptic drug augmentation for treatment-resistant depression.
Topics: Alprazolam; Anticonvulsants; Antidepressive Agents; Clonazepam; Comorbidity; Depressive Disorder; Di | 1997 |
[Depression after age 50. Clinical case].
Topics: Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Female; Humans; | 2000 |
Seasonal panic disorder: a possible variant of seasonal affective disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Circadian Rhythm; Combined Modality Therapy; Depressive Disord | 1992 |
Characteristics of long-term alprazolam users in the community.
Topics: Alprazolam; Attitude to Health; Depressive Disorder; Drug Administration Schedule; Humans; Panic Dis | 1992 |
Suicide and violence associated with panic attacks.
Topics: Adult; Alprazolam; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; | 1992 |
Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.
Topics: Adult; Alprazolam; Bipolar Disorder; Depressive Disorder; Female; Follow-Up Studies; Humans; Imipram | 1991 |
Pharmacokinetics of alprazolam in geriatric patients with neurotic depression.
Topics: Aged; Aged, 80 and over; Alprazolam; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychia | 1991 |
Prescription-event monitoring of 10,895 patients treated with alprazolam.
Topics: Adult; Aged; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Overdose; Female; Follow-Up St | 1991 |
Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study.
Topics: Alprazolam; Anxiety Disorders; Child, Preschool; Chronic Disease; Clonazepam; Cognitive Behavioral T | 1990 |
Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Benzodiazepines; Combat Disorders; Depressive Disorder; Homici | 1990 |
Alprazolam withdrawal symptoms.
Topics: Aged; Alprazolam; Depressive Disorder; Female; Hallucinations; Humans; Paranoid Disorders; Substance | 1990 |
Alprazolam.
Topics: Adult; Alprazolam; Depressive Disorder; Humans | 1989 |
Trials of adjunctive alprazolam in "negative symptom" patients.
Topics: Adult; Alprazolam; Depressive Disorder; Drug Therapy, Combination; Fluphenazine; Hallucinations; Hum | 1989 |
Alprazolam in the treatment of endogenous depressions.
Topics: Alprazolam; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Female; Hu | 1989 |
Depression in panic disorder and response to alprazolam therapy.
Topics: Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Fear; Humans; Panic; Psychiatric St | 1989 |
Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Behavior Therapy; Combined Modality Therapy; Depr | 1989 |
Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase.
Topics: Adenylyl Cyclases; Adult; Alprazolam; Blood Platelets; Catecholamines; Depressive Disorder; Dexameth | 1988 |
Alprazolam in severe depression.
Topics: Acute Disease; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depressive Disorder; Female; | 1985 |
Alprazolam and hostility.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depressive Disorder; Dreams; Drug Therapy, | 1985 |
Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam.
Topics: Adult; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depressive Disorder; Female; Glycols; | 1985 |
Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Biogenic Amines; B | 1985 |
[Alprazolam (Tafil). A new benzodiazepine-with a new action profile?].
Topics: Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Depressive Disorder; Humans; Panic | 1985 |
Alprazolam-induced manic episode in two patients with panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bipolar Dis | 1986 |
Alprazolam-induced manic reaction.
Topics: Agoraphobia; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder | 1986 |
Dangerously aggressive behavior as a side effect of alprazolam.
Topics: Adult; Aggression; Alprazolam; Brain Injuries; Dangerous Behavior; Depressive Disorder; Humans; Male | 1989 |
Alprazolam for psychotic depression.
Topics: Adult; Alprazolam; Amitriptyline; Depressive Disorder; Female; Humans; Male; Perphenazine; Psycholog | 1989 |
Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: preliminary data.
Topics: Adenylyl Cyclases; Adult; Aged; Alprazolam; Antidepressive Agents; Benzodiazepines; Blood Platelets; | 1985 |
Urinary MHPG-sulfate and urinary MHPG-glucuronide, two possible markers of the central or peripheral norepinephrine metabolism in man. The effect of alprazolam treatment.
Topics: Alprazolam; Biomarkers; Depressive Disorder; Glycols; Humans; Methoxyhydroxyphenylglycol; Norepineph | 1988 |
Alprazolam response in major depression: relationship with urinary levels of MHPG-sulfate.
Topics: Adult; Alprazolam; Biomarkers; Depressive Disorder; Female; Glycols; Humans; Male; Methoxyhydroxyphe | 1988 |
Alprazolam dependence in seven patients.
Topics: Adult; Alcoholism; Alprazolam; Anxiety Disorders; Depressive Disorder; Female; Humans; Male; Marijua | 1988 |
Alprazolam in the treatment of panic attack patients with and without major depression.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Depressive Disorder; Fear; Female; Humans; Male; | 1988 |
Alprazolam does not inhibit the metabolism of nortriptyline in depressed patients or inhibit the metabolism of desipramine in human liver microsomes.
Topics: Adult; Alprazolam; Depressive Disorder; Desipramine; Drug Interactions; Female; Humans; Hydroxylatio | 1988 |
Behavioral dyscontrol associated with combined use of alprazolam and ethanol.
Topics: Adult; Alcohol Drinking; Alprazolam; Amnesia; Depressive Disorder; Drug Interactions; Ethanol; Femal | 1988 |
Paranoid reaction following alprazolam withdrawal.
Topics: Adult; Alprazolam; Depressive Disorder; Female; Humans; Paranoid Behavior; Substance Withdrawal Synd | 1987 |
Successful treatment of depression with alprazolam in a severely medically ill patient.
Topics: Alprazolam; Depressive Disorder; Drug Administration Schedule; Female; Humans; Hypertension; Middle | 1987 |
The specificity of drug classes for the anxiety and depressive disorders.
Topics: Adult; Aged; Alprazolam; Amitriptyline; Anxiety; Depressive Disorder; Female; Humans; Middle Aged; P | 1986 |
Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Fear; Female; | 1987 |
Treatment of agitated depression with alprazolam.
Topics: Alprazolam; Depressive Disorder; Female; Humans; Middle Aged; Psychomotor Agitation | 1987 |
Combined alprazolam and phenelzine treatment of refractory depression with panic attacks.
Topics: Adult; Alprazolam; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Fear; Humans; | 1987 |
Analgesic effect of alprazolam in patients with chronic, organic pain of malignant origin.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Alprazolam; Causalgia; Chronic Disease; Depressive Di | 1987 |
Alprazolam in treating secondary depression.
Topics: Alcoholism; Alprazolam; Depressive Disorder; Humans; Substance-Related Disorders | 1987 |
Synergistic action of alprazolam with tranylcypromine in drug-resistant atypical depression with panic attacks.
Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Depressive Disorder; Drug Res | 1986 |
A difficult alprazolam withdrawal.
Topics: Adult; Akathisia, Drug-Induced; Alprazolam; Benzodiazepines; Depressive Disorder; Female; Humans; Sp | 1986 |
Alprazolam and desipramine in moderately severe depression.
Topics: Alprazolam; Benzodiazepines; Depressive Disorder; Desipramine; Humans | 1986 |
Agitated depression, alprazolam, and panic anxiety.
Topics: Adult; Aged; Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Depressive Disor | 1986 |
Alprazolam in depression.
Topics: Alprazolam; Depressive Disorder; Humans | 1986 |
Alprazolam as an antidepressant.
Topics: Aged; Alprazolam; Antidepressive Agents; Benzodiazepines; Depressive Disorder; Humans; Male | 1985 |
A proposed clinical approach to chronic and "resistant" depressions: evaluation and treatment.
Topics: Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepi | 1985 |